Holen Sie sich die Stockscreener-App
23.80
0.02%
-0.005
Handel nachbörslich:
23.81
0.005
+0.02%
Schlusskurs vom Vortag:
$23.81
Offen:
$23.805
24-Stunden-Volumen:
135
Relative Volume:
0.54
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+1.45%
1M Leistung:
+3.89%
6M Leistung:
-7.67%
1J Leistung:
-8.19%
1-Tages-Spanne:
$23.80
$23.80
1-Wochen-Bereich:
$23.37
$23.81
52-Wochen-Spanne:
$19.86
$27.66
Tema Neuroscience And Mental Health Etf Stock (MNTL) Company Profile
Firmenname
Tema Neuroscience And Mental Health Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MNTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNTL
Tema Neuroscience And Mental Health Etf
|
23.80 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
311.25 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
632.78 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
635.79 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
240.73 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
567.32 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Neuroscience And Mental Health Etf Aktie (MNTL) Neueste Nachrichten
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – June 30-July 4, 2025 - Trackinsight
Tema Announces Liquidation of Two ETFs - Business Wire
The Unseen Storm: How Section 899 Could Trigger a Foreign Capital Exodus from U.S. Equities - AInvest
Tema Launches the S&P 500 Historical Weight ETF Strategy (DSPY), First S&P 500 Concentration Innovation Since 2003 - Business Wire
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com
Hone Your Biotech Allocation With Neuroscience ETF MNTL - ETF Trends
Tema Launches World’s First Electrification ETF ($VOLT) - Business Wire
Investing in Nobel Prize Achievements – Neurons & Brain Architecture - Securities.io
Where to Invest in Health Trends - Bloomberg
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start - Reuters
Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health? - Benzinga
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
Active ETF Stat Pack - NYSE
This Week in ETFs: Closures Outnumber New ETFs - ETF Trends
Biotechnology ETF List - ETFdb.com
Finanzdaten der Tema Neuroscience And Mental Health Etf-Aktie (MNTL)
Es liegen keine Finanzdaten für Tema Neuroscience And Mental Health Etf (MNTL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
1.35%
Kapitalisierung:
|
Volumen (24h):